The global nicotine replacement therapy NRT products market is projected to be worth USD 13.8 billion by 2028, growing at a CAGR of 5.2% during the forecast period 2018-2028. The NRT products market in North America was valued at around USD 3.3 billion in 2017 and is expected to account for over 30% share of the global revenue by 2020 owing to the high prevalence of smoking, increasing number of smokers switching from cigarettes to other forms of tobacco consumption such as smokeless tobacco and e-cigarettes, rising government regulations on tobacco use coupled with higher spending power due to low unemployment rates among others factors are driving this region's growth.
Nicotine replacement therapy NRT products help to reduce cravings and withdrawal symptoms from the person who wants to quit smoking. NRT is a nicotine replacement therapy comprising of products that help smokers gradually reduce their dependence on tobacco, primarily by replacing the nicotine in cigarettes. NRTs are available as chewing gums, patches, and sprays which can be bought over-the-counter at pharmacies or online in some countries.
The use of these aids helps to prevent withdrawal symptoms and reduce the craving for cigarettes. NRTs are different from drugs that treat nicotine addiction, which is given as a treatment only to those who have failed with other methods of quitting smoking.
NRT products help smokers in three ways:
- Helping them to stop by reducing their cravings
- Reducing the risk of heart disease
- Lowering chances of a stroke or developing lung cancer
On the basis of type, the global nicotine replacement therapy NRT products market is segmented into Sprays, Inhalers, Chewing gums, Transdermal patches, Lozenges, Sublingual tablets.
This type of nicotine replacement therapy is applied to the mucous membranes in the mouth. They are usually available as solutions or suspensions, and they come with a manual pump that sprays them into your mouth This type has been found more effective than other types because it causes less nausea and does not require chewing/swallowing.
This type of nicotine replacement therapy is usually used as a last resort for smokers who cannot quit with the other types. They are more expensive than all the others because they contain a form of concentrated tobacco that has been dissolved in the water This type has shown to be effective, but it is also one of the most toxic types.
This type of nicotine replacement therapy is available as a non-nicotine gum that helps smokers quit by providing the oral stimulation and satisfaction they need to curb cravings This type has shown to be effective because it provides such little amount of nicotine, which reduces its addictive power.
This type of nicotine replacement therapy is used by smoking adults who are addicted to cigarettes and need a way out. It releases the nicotine through the skin over time, which can be helpful in reducing withdrawal symptoms
These types of nicotine replacement therapies have shown that smokers find them more enjoyable because they provide an oral sensation The lozenges can be beneficial for smokers who have a hard time quitting because they offer an oral fix to help curb smoking urges The lozenge, however, contains more nicotine than the gum.
Sublingual tablets are a form of nicotine replacement therapy that is placed under the tongue and absorbed through mucous membranes. Unlike other forms of NRTs, this type does not require chewing or swallowing; it can be taken anytime throughout the day. This way smokers don't need to worry about setting time aside for use because they can take it anywhere. A sublingual tablet is a great option for smokers who are looking to feel the effects of nicotine but would like an alternative form than those offered by other NRTs such as gum, lozenges, or inhalers. The sublingual tablets can be beneficial because they provide quick relief and act quickly; coming in different doses they can be tailored to the smoker's needs.
On the basis of application, the global nicotine replacement therapy NRT products market is segmented into Home Application and Hospital Application.
The home application can be used to provide relief from nicotine withdrawal symptoms and for smoking cessation. Nicotine replacement therapy products are available in various forms such as inhalers, transdermal patches, chewing gums, lozenges, and sublingual tablets that dissolve under the tongue. On the basis of product type, it is segmented into Sprays, Inhalers, Chewing gums, and Transdermal patches. Hospital application of NRT products is being used for smoking cessation in the hospital setting.
On the basis of region, the global nicotine replacement therapy NRT products market is segmented into North America, Latin America, Europe, and the Asia Pacific. North America is the largest market for nicotine replacement therapy NRT products in terms of generating revenue from both home and hospital applications; whereas, the Asia-Pacific region has generated more revenue from hospital applications than any other region.
The growth of the global nicotine replacement therapy NRT products market can be attributed to factors such as increased prevalence and incidence rates for tobacco use disorders across the globe coupled with government regulations on tobacco use across various regions.
The global nicotine replacement therapy NRT products market has been witnessing a steady rise in growth, owing to factors such as increased prevalence and incidence rates for tobacco use disorders across the globe coupled with government regulations on tobacco use across various regions.
Up Market Research published a new report titled “Nicotine Replacement Therapy NRT Products Market research report which is segmented by Types (Sprays, Inhalers, Chewing gums, Transdermal patches, Lozenges, Sublingual tablets), By Applications (Home, Hospital), By Players/Companies Pfizer, Cipla, Novartis, GlaxoSmithKline, Takeda, McNeil, Revolymer, Imperial Tobacco, VMR products”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
|Report Attributes||Report Details|
|Report Title||Nicotine Replacement Therapy NRT Products Market Research Report|
|By Type||Sprays, Inhalers, Chewing gums, Transdermal patches, Lozenges, Sublingual tablets|
|By Application||Home, Hospital|
|By Companies||Pfizer, Cipla, Novartis, GlaxoSmithKline, Takeda, McNeil, Revolymer, Imperial Tobacco, VMR products|
|Regions Covered||North America, Europe, APAC, Latin America, MEA|
|Historical Year||2018 to 2019 (Data from 2010 can be provided as per availability)|
|Number of Pages||219|
|Number of Tables & Figures||154|
|Customization Available||Yes, the report can be customized as per your need.|
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
The market is segmented by Type Sprays, Inhalers, Chewing gums, Transdermal patches, Lozenges, Sublingual tablets and By Application Home, Hospital.
Some of the companies that are profiled in this report are:
Nicotine Replacement Therapy NRT Products Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
We have studied the Nicotine Replacement Therapy NRT Products Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
Reasons to Purchase the Nicotine Replacement Therapy NRT Products Market Report:
Some other reports from this category!